Tyra Biosciences, Inc. (TYRA)
NASDAQ: TYRA · Real-Time Price · USD
15.84
+0.16 (1.02%)
At close: Oct 31, 2025, 4:00 PM EDT
15.88
+0.04 (0.25%)
After-hours: Oct 31, 2025, 4:31 PM EDT
Tyra Biosciences Market Cap
Tyra Biosciences has a market cap or net worth of $844.23 million as of October 31, 2025. Its market cap has decreased by -34.64% in one year.
Market Cap
844.23M
Enterprise Value
553.98M
1-Year Change
-34.64%
Ranking
Category
Stock Price
$15.84
Market Cap Chart
Since the IPO on September 15, 2021, Tyra Biosciences's market cap has increased from $654.64M to $844.23M, an increase of 28.96%. That is a compound annual growth rate of 6.36%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 30, 2025 | 835.70M | 14.29% |
| Dec 31, 2024 | 731.18M | 22.61% |
| Dec 29, 2023 | 596.34M | 87.61% |
| Dec 30, 2022 | 317.87M | -44.42% |
| Dec 31, 2021 | 571.90M | -12.64% |
| Sep 15, 2021 | 654.64M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 730.33B |
| Johnson & Johnson | 449.57B |
| AbbVie | 397.72B |
| UnitedHealth Group | 321.75B |
| AstraZeneca | 257.84B |
| Novartis AG | 237.42B |
| Novo Nordisk | 232.34B |
| Abbott Laboratories | 216.57B |